Puma Biotechnology (PBYI) - 5 Price Charts 2012-2022 (History)
Puma Biotech In-Licenses Takeda's Cancer Candidate With Primary Focus On Breast & Lung Cancer
Puma Biotechnology Reports First Quarter 2022 Financial Results | Business Wire
![Puma Biotechnology Inc (PBYI) Stock 5 Years History [Returns & Performance]](https://www.netcials.com/tools/phpgraphlib-master/image/nasdaq-stock-5years/5-year-monthly-price-chart-Puma-Biotechnology-Inc.png "Puma Biotechnology Inc (PBYI) Stock 5 Years History [Returns & Performance]")
Puma Biotechnology Inc (PBYI) Stock 5 Years History [Returns & Performance]
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat
Puma Biotechnology
Here's Why Puma Biotechnology Inc. Is Getting Beaten Down Today | The Motley Fool
Articles with Puma Biotechnology
With 53% institutional ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) is a favorite amongst the big guns | Nasdaq
With 53% institutional ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) is a favorite amongst the big guns | Nasdaq
Puma Biotechnology Reports Third Quarter 2021 Financial Results | Business Wire
Here's Why The Puma Biotechnology Inc (NYSE:PBYI) Pullback Might Be A Buy-In Opportunity - Market Exclusive
Here's Why Puma Biotechnology, Inc. (PBYI) is Down on Tuesday
Puma Biotechnology Reports Third Quarter 2021 Financial Results | Business Wire
Puma Biotechnology - Crunchbase Company Profile & Funding
Puma Biotechnology Inc (PBYI): Hedge Funds Taking Some Chips Off The Table
Puma Biotechnology (PBYI) - 5 Price Charts 2012-2022 (History)
Breakeven On The Horizon For Puma Biotechnology, Inc. (NASDAQ:PBYI) | Nasdaq
Puma Biotechnology (PBYI) - 5 Price Charts 2012-2022 (History)
PBYI | Puma Biotechnology Inc. Stock Overview (U.S.: Nasdaq) | Barron's
Puma Biotechnology (NasdaqGS:PBYI) Stock Price & Quote Analysis - Simply Wall St
Puma Biotechnology
Puma Biotechnology Surging
